Associated Papers
Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approaches.
Depasse F et al.
Expert Review of Hematology, 2025
Structure-resolved dynamics of type 2M von Willebrand disease.
Tischer A et al.
Journal of Thrombosis and Haemostasis : Jth, 2025
Challenges and considerations of genetic testing in von Willebrand disease.
Seidizadeh O et al.
Research and Practice in Thrombosis and Haemostasis, 2025
von Willebrand factor binds to angiopoietin-2 within endothelial cells and after release from Weibel-Palade bodies.
Mobayen G et al.
Journal of Thrombosis and Haemostasis : Jth, 2023
Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives.
Castaman G et al.
Journal of Blood Medicine, 2021
New developments in von Willebrand disease.
Fogarty H et al.
British Journal of Haematology, 2020
Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimers.
Szederjesi A et al.
Journal of Thrombosis and Haemostasis : Jth, 2020
Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics.
Tischer A et al.
Journal of Thrombosis and Haemostasis : Jth, 2020
The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.
Flood VH et al.
Current Opinion in Hematology, 2019
von Willebrand factor/ADAMTS-13 interactions at birth: implications for thrombosis in the neonatal period.
Katneni UK et al.
Journal of Thrombosis and Haemostasis : Jth, 2019
An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study.
Szederjesi A et al.
Journal of Thrombosis and Haemostasis : Jth, 2018
Current approaches to diagnostic testing in von Willebrand Disease.
Rao ES et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis, 2018
Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges.
Hayward CP et al.
International Journal of Laboratory Hematology, 2014
Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
Flood VH et al.
Blood, 2011
Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.
Flood VH et al.
Blood, 2010
Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.
Flood VH et al.
Journal of Thrombosis and Haemostasis : Jth, 2009
Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A et al.
Acta Haematologica, 2009